CONSULTING AGREEMENTConsulting Agreement • April 27th, 2012 • Biospecifics Technologies Corp • Pharmaceutical preparations • New York
Contract Type FiledApril 27th, 2012 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (this “Agreement”), is made effective as of July 1, 2012 (“Effective Date”), by and between BioSpecifics Technologies Corp. (the “Company”), a Delaware corporation, Dr. Matthew Geller, an individual (“Dr. Geller”), and Geller Biopharm Inc., a New York corporation (“Consultant”), of which Dr. Geller is President.